OGN News and Press, Organon & Co. From 11/03/23

2023-11-03 00:55:40 ET Summary SPDR S&P 600 Small Cap Value ETF is invested in over 400 small caps with a tilt to value over growth. It is well-diversified across sectors and holdings. The sector breakdown, valuation ratios and historical performance are not much different...

2023-11-02 13:29:17 ET Shares of Organon ( NYSE: OGN ) on Thursday slumped as much as 12.5% to a record low of $12.83, after the company saw a quarterly revenue decline in its main women's health business. Pharmaceutical giant Merck ( MRK ) spun-off Organon ( OGN ) i...

2023-11-02 12:21:05 ET Organon & Co (OGN) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO Matthew Walsh - CFO Sandra Milligan - Head of R&D Conference Call Participants ...

2023-11-02 09:00:00 ET Summary Pfizer's stock has dropped due to a decline in revenues post-COVID, presenting a value investment opportunity. The company still generates significant gross profit and has a strong revenue growth rate. Pfizer's low Price-to-Earnings ratio and imp...

2023-11-02 07:31:27 ET More on Organon Organon: The Federal Reserve Black Swan (Rating Upgrade) 6% Yield And Significantly Undervalued: A Closer Look At Organon Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk Organon Q3 2023 Earning...

Third quarter 2023 revenue of $1,519 million Third quarter 2023 diluted earnings per share of $0.23 and non-GAAP Adjusted diluted earnings per share of $0.87 Adjusted EBITDA of $447 million Board of Directors declares quarterly dividend of $0.28 per share Full year 2023 financial ...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Organon & Co. (OGN) is expected to report $1.04 for Q3 2023

2023-11-01 12:56:56 ET More on Organon Organon: The Federal Reserve Black Swan (Rating Upgrade) 6% Yield And Significantly Undervalued: A Closer Look At Organon Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk Hennessy Funds is bulli...

Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on time and improve adherence through an innovative pricing program that offers personalized support. This press release features multimedia. View ...